We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

3 hedge funds and large institutions have $2.16M invested in SpringWorks Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 217 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 222 → 3 (-219)

99.54% less ownership

Funds ownership: 99.59% → 0.05% (-100%)

100% less capital invested

Capital invested by funds: $3.53B → $2.16M (-$3.52B)

100% less funds holding in top 10

Funds holding in top 10: 18 → 0 (-18)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 217

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
-219
Holders Change %
-98.65%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
-18
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
217
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$341M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$335M
3
GCL
Glazer Capital LLC
New York
-$193M
4
Fidelity International
Fidelity International
Bermuda
-$142M
5
State Street
State Street
Massachusetts
-$141M
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
51
Verition Fund Management
Connecticut
– -$14.7M -313,408 Closed
Bank of America
52
Bank of America
North Carolina
– -$13.3M -283,416 Closed
LP
53
LMR Partners
United Kingdom
– -$13.1M -279,700 Closed
VI
54
Vestcor Inc
New Brunswick, Canada
– -$11.7M -250,000 Closed
Man Group
55
Man Group
United Kingdom
– -$11.7M -248,995 Closed
SCS
56
Syquant Capital SAS
France
– -$11.6M -247,000 Closed
CIEC
57
Crédit Industriel et Commercial
France
– -$11.4M -242,834 Closed
PAM
58
PSquared Asset Management
Switzerland
– -$10.1M -216,000 Closed
Squarepoint
59
Squarepoint
New York
– -$9.6M -204,271 Closed
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
– -$9.45M -201,100 Closed
Bank of New York Mellon
61
Bank of New York Mellon
New York
– -$9.43M -200,634 Closed
CCM
62
Chicago Capital Management
Illinois
– -$9.41M -200,230 Closed
Marshall Wace
63
Marshall Wace
United Kingdom
– -$8.72M -185,540 Closed
UBS AM
64
UBS AM
Illinois
– -$8.3M -176,719 Closed
PMAM
65
Picton Mahoney Asset Management
Ontario, Canada
– -$8.22M -175,000 Closed
N
66
Nuveen
North Carolina
– -$8.13M -173,109 Closed
PCM
67
Prelude Capital Management
New York
– -$8.07M -171,716 Closed
GLF
68
Groupe la Francaise
France
– -$7.7M -163,935 Closed
CG
69
Carmignac Gestion
France
– -$6.99M -148,806 Closed
GI
70
GAMCO Investors
Connecticut
– -$6.42M -136,600 Closed
PIP
71
Palisades Investment Partners
California
– -$6.23M -132,555 Closed
TMAM
72
Tokio Marine Asset Management
Japan
– -$6.18M -131,600 Closed
Rafferty Asset Management
73
Rafferty Asset Management
New York
– -$5.36M -114,006 Closed
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
– -$5.33M -113,415 Closed
AA
75
ABC Arbitrage
France
– -$5.06M -107,630 Closed
1 2
3
4 5

SWTX Hedge Fund Activity: Q3 2025 in Review

3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2025, worth a combined $2.16M — down 100% from $3.53B a quarter earlier.

Sellers outnumbered buyers: 217 funds closed out of SWTX and 0 opened new positions — a net loss of 217 holders — while 2 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $341M sold.

  • 3 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2025, down from 222 in Q2 2025.
  • Funds reported $2.16M of SpringWorks Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new SpringWorks Therapeutics positions in Q3 2025 and 217 closed out, a net change of -217 holders.
  • The largest SpringWorks Therapeutics seller in Q3 2025 was BlackRock, an estimated $341M sold.

Based on aggregated 13F filings for Q3 2025.